AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32603281 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surgical therapies (MISTs)
Number of subjects: 0
Study 32603281 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment (drugs)
Number of subjects: 0
Study 35189848 — intervention group
Group type: EXPERIMENTAL
Intervention: Group self-management support (10 weekly 2.5-hour group web-based sessions with 10-15 patients and two trained facilitators)
Number of subjects: 0
Study 35189848 — intervention group
Group type: EXPERIMENTAL
Intervention: Group self-management support
Number of subjects: 0
Study 35189848 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 0
Study 34133958 — intervention group
Group type: EXPERIMENTAL
Intervention: DL‐PDT + CO2 laser
Number of subjects: 40
Study 34133958 — intervention group
Group type: EXPERIMENTAL
Intervention: DL‐PDT + microdermabrasion
Number of subjects: 40
Study 34133958 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard DL‐PDT
Number of subjects: 40
Study 34133958 — intervention group
Group type: EXPERIMENTAL
Intervention: DL‐PDT + microneedles
Number of subjects: 40
Study 34133958 — intervention group
Group type: COMPARATOR
Intervention: Control group (Standard DL‐PDT)
Number of subjects: 40
Study 36470757 — intervention group
Group type: EXPERIMENTAL
Intervention: Social media-based drama therapy
Number of subjects: 330
Study 36470757 — intervention group
Group type: EXPERIMENTAL
Intervention: Social media-based art therapy
Number of subjects: 330
Study 36470757 — intervention group
Group type: EXPERIMENTAL
Intervention: Social media-based music therapy
Number of subjects: 330
Study 36470757 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 330
Study 34461035 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (STAMP intervention): Brief telephone or web-based assessment generating a mailed, individually tailored feedback report with a stage-matched brochure at baseline, 2 months, and 4 months.
Number of subjects: 909
Study 34461035 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control group):
Number of subjects: 909
Study 34461035 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (STAMP intervention):
Number of subjects: 909
Study 32615357 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepwise salt supply control (SSSC) with salt substitute (SS)
Number of subjects: 1606
Study 32615357 — intervention group
Group type: COMPARATOR
Intervention: Stepwise salt supply control (SSSC) only
Number of subjects: 1606
Study 32615357 — intervention group
Group type: COMPARATOR
Intervention: Salt substitute (SS) only
Number of subjects: 1606
Study 32615357 — intervention group
Group type: COMPARATOR
Intervention: Neither SSSC nor SS
Number of subjects: 1606
Study 32615357 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 1606
Study 33588630 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet soda
Number of subjects: 0
Study 33588630 — intervention group
Group type: COMPARATOR
Intervention: Carbonated water
Number of subjects: 0
Study 33588630 — intervention group
Group type: COMPARATOR
Intervention: Regular soda
Number of subjects: 0
Study 32562324 — intervention group
Group type: EXPERIMENTAL
Intervention: Monolithic zirconia crown (Mono‐ZrO2)
Number of subjects: 76
Study 32562324 — intervention group
Group type: COMPARATOR
Intervention: Porcelain-fused-to-metal (PFM) crown
Number of subjects: 76
Study 35393218 — intervention group
Group type: EXPERIMENTAL
Intervention: Full 90-minute HBOT dose in a pressurized chamber with 100% oxygen at 2.0 ATA
Number of subjects: 8
Study 35393218 — intervention group
Group type: COMPARATOR
Intervention: Sham condition receiving 21% oxygen at a minimal pressure of ≤1.3 ATA
Number of subjects: 8
Study 35393218 — intervention group
Group type: EXPERIMENTAL
Intervention: Full 90-minute HBOT dose
Number of subjects: 8
Study 35393218 — intervention group
Group type: COMPARATOR
Intervention: Sham condition
Number of subjects: 8
Study 33778908 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) three times per week for 6 months
Number of subjects: 65
Study 33778908 — intervention group
Group type: COMPARATOR
Intervention: Control (non-intervention)
Number of subjects: 65
Study 33778908 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 65
Study 32985114 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Weight Loss (BWL)
Number of subjects: 191
Study 32985114 — intervention group
Group type: COMPARATOR
Intervention: Stepped Care
Number of subjects: 191
Study 33098411 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (80 mg once daily)
Number of subjects: 80
Study 33098411 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 33891380 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimekizumab (320 mg subcutaneously every 4 weeks)
Number of subjects: 743
Study 33891380 — intervention group
Group type: COMPARATOR
Intervention: Secukinumab (300 mg subcutaneously weekly to week 4, then every 4 weeks)
Number of subjects: 743
Study 33891380 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimekizumab
Number of subjects: 743
Study 33891380 — intervention group
Group type: COMPARATOR
Intervention: Secukinumab
Number of subjects: 743
Study 36153547 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive book sharing intervention
Number of subjects: 115
Study 36153547 — intervention group
Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 115
Study 32434492 — intervention group
Group type: EXPERIMENTAL
Intervention: Loneliness at baseline (measured using the UCLA Loneliness Scale)
Number of subjects: 399
Study 616399850 — intervention group
Group type: EXPERIMENTAL
Intervention: Hands-on learning with a bench model simulator
Number of subjects: 86
Study 616399850 — intervention group
Group type: COMPARATOR
Intervention: Video-learning using an instructional video
Number of subjects: 86
Study 34172470 — intervention group
Group type: COMPARATOR
Intervention: Stopping mepolizumab (switch to placebo)
Number of subjects: 295
Study 34172470 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuing mepolizumab 100 mg every 4 weeks
Number of subjects: 295
Study 34247980 — intervention group
Group type: EXPERIMENTAL
Intervention: GDFT-hydroxyethyl starch (GH)
Number of subjects: 75
Study 34247980 — intervention group
Group type: EXPERIMENTAL
Intervention: GDFT-lactated Ringer's (GL)
Number of subjects: 75
Study 34247980 — intervention group
Group type: COMPARATOR
Intervention: Conventional fluid therapy (Control)
Number of subjects: 75
Study 34909045 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine (1.5 g daily for six days)
Number of subjects: 48
Study 34909045 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 36094578 — intervention group
Group type: COMPARATOR
Intervention: Cold-water immersion at 10°C (CON)
Number of subjects: 12
Study 36094578 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold-water immersion at 17°C with 75.7L ice added (ICE)
Number of subjects: 12
Study 33765054 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine (18 mg intravenous bolus)
Number of subjects: 46
Study 32831540 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior TAP block
Number of subjects: 82
Study 32831540 — intervention group
Group type: COMPARATOR
Intervention: Lateral TAP block
Number of subjects: 82
Study 34166000 — intervention group
Group type: EXPERIMENTAL
Intervention: Access to a decision support system (n = 335)
Number of subjects: 538
Study 34166000 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (n = 203)
Number of subjects: 538
Study 35430238 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg ulipristal acetate daily
Number of subjects: 180
Study 35430238 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg ulipristal acetate daily
Number of subjects: 180
Study 35430238 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic regimen of 5 mg ulipristal acetate for 24 days followed by four placebo days
Number of subjects: 180
Study 35430238 — intervention group
Group type: EXPERIMENTAL
Intervention: All ulipristal acetate treatments
Number of subjects: 180
Study 35430238 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI > 32 kg/m2
Number of subjects: 180
Study 35430238 — intervention group
Group type: EXPERIMENTAL
Intervention: Endometrial biopsies during treatment
Number of subjects: 180
Study 35430238 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg ulipristal acetate
Number of subjects: 180
Study 35430238 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg ulipristal acetate
Number of subjects: 180
Study 35430238 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic regimen of 5 mg ulipristal acetate
Number of subjects: 180
Study 35430238 — intervention group
Group type: EXPERIMENTAL
Intervention: Liver transaminase changes
Number of subjects: 180
Study 33496796 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT-D
Number of subjects: 3100
Study 33496796 — intervention group
Group type: COMPARATOR
Intervention: DC-ICD
Number of subjects: 3100
Study 32847927 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam or Zonisamide (new AEDs)
Number of subjects: 1510
Study 32847927 — intervention group
Group type: COMPARATOR
Intervention: Standard AED (lamotrigine for focal epilepsy, sodium valproate for generalized epilepsy)
Number of subjects: 1510
Study 32847927 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (new AED)
Number of subjects: 1510
Study 32847927 — intervention group
Group type: COMPARATOR
Intervention: Standard AED (lamotrigine or sodium valproate)
Number of subjects: 1510
Study 34792161 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dialysate sodium concentration (142 mmol/L)
Number of subjects: 139
Study 34792161 — intervention group
Group type: COMPARATOR
Intervention: Lower dialysate sodium concentration (138 mmol/L)
Number of subjects: 139
Study 32562632 — intervention group
Group type: EXPERIMENTAL
Intervention: Late-parenteral nutrition
Number of subjects: 684
Study 32562632 — intervention group
Group type: COMPARATOR
Intervention: Early-parenteral nutrition
Number of subjects: 684
Study 33280489 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical abuse without a weapon
Number of subjects: 3011
Study 33280489 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical abuse with a weapon
Number of subjects: 3011
Study 33280489 — intervention group
Group type: EXPERIMENTAL
Intervention: Attempted rape without penetration
Number of subjects: 3011
Study 33280489 — intervention group
Group type: EXPERIMENTAL
Intervention: Attempted rape with penetration
Number of subjects: 3011
Study 33280489 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal sexual harassment
Number of subjects: 3011
Study 32303829 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary nitrate (4.03 mmol NO3- and 0.29 mmol NO2-)
Number of subjects: 10
Study 32303829 — intervention group
Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 10
Study 32125792 — intervention group
Group type: EXPERIMENTAL
Intervention: Restricted CF group (n=44)
Number of subjects: 89
Study 32125792 — intervention group
Group type: COMPARATOR
Intervention: Non-CF group (n=45)
Number of subjects: 89
Study 32125792 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 89
Study 35112386 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential Health Care Programme (EHCP) - daily toothbrushing with fluoride toothpaste
Number of subjects: 682
Study 35112386 — intervention group
Group type: EXPERIMENTAL
Intervention: EHCP + Fluoride - weekly application of high-concentrated fluoride gel
Number of subjects: 682
Study 35112386 — intervention group
Group type: EXPERIMENTAL
Intervention: EHCP + OUT - twice-yearly access to on-demand urgent oral treatment
Number of subjects: 682
Study 35112386 — intervention group
Group type: COMPARATOR
Intervention: Control group - standard school-based oral health education
Number of subjects: 682
Study 33649613 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 220
Study 33649613 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 220
Study 33649613 — intervention group
Group type: COMPARATOR
Intervention: Nicorandil
Number of subjects: 220
Study 32073559 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid eye drops (Group A)
Number of subjects: 21
Study 32073559 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastroftal eye drops and tablets (Group B)
Number of subjects: 21
Study 36481516 — intervention group
Group type: EXPERIMENTAL
Intervention: 3P intervention (combination of imaginal retraining and decoupling)
Number of subjects: 227
Study 36481516 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 227
Study 36481516 — intervention group
Group type: COMPARATOR
Intervention: Active control conditions (two types)
Number of subjects: 227
Study 34224598 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous perineal electrostimulation (intervention group, IG)
Number of subjects: 70
Study 34224598 — intervention group
Group type: COMPARATOR
Intervention: Intracavitary anal electrostimulation (control group, CG)
Number of subjects: 70
Study 34224598 — intervention group
Group type: EXPERIMENTAL
Intervention: Both IG and CG
Number of subjects: 70
Study 32126454 — intervention group
Group type: EXPERIMENTAL
Intervention: Current tobacco use
Number of subjects: 798
Study 32126454 — intervention group
Group type: EXPERIMENTAL
Intervention: Current tobacco use (adjusted)
Number of subjects: 798
Study 32126454 — intervention group
Group type: EXPERIMENTAL
Intervention: Other factors (age, marital status, financial status, education, pain severity)
Number of subjects: 798
Study 34366425 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-lung strategy (OLS) with PEEP of 6-8 cmH2O and repeated LRMs every 30 minutes
Number of subjects: 280
Study 34366425 — intervention group
Group type: COMPARATOR
Intervention: Zero PEEP without LRMs (non-OLS group)
Number of subjects: 280
Study 34366425 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-lung strategy (OLS)
Number of subjects: 280
Study 36090002 — intervention group
Group type: EXPERIMENTAL
Intervention: Jintiange capsules (1.2 g each time, 3 times per day) and alfacalcidol (0.25 μg/d)
Number of subjects: 400
Study 36090002 — intervention group
Group type: COMPARATOR
Intervention: Calcium carbonate (element calcium 0.3 g, twice a day) and alfacalcidol (0.25 μg/d)
Number of subjects: 400
Study 36066032 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D foot scanner app for selecting therapeutic footwear
Number of subjects: 30
Study 36066032 — intervention group
Group type: COMPARATOR
Intervention: Control group (aesthetic preferences for TF size and model)
Number of subjects: 30
Study 35010445 — intervention group
Group type: EXPERIMENTAL
Intervention: e-mail-delivered cognitive behavioral therapy for insomnia (CBT-I) (REFRESH)
Number of subjects: 48
Study 35010445 — intervention group
Group type: COMPARATOR
Intervention: self-monitoring (SM) with sleep diaries
Number of subjects: 48
Study 34894470 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg terazosin (TZ)
Number of subjects: 13
Study 34894470 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 34077998 — intervention group
Group type: EXPERIMENTAL
Intervention: Immune-related lncRNA prognostic signature model
Number of subjects: 356
Study 34077998 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk group
Number of subjects: 356
Study 34077998 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-risk group
Number of subjects: 356
Study 34077998 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk score
Number of subjects: 356
Study 32989771 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual parent-training program with e-learning modules and scripted role-play via a VPN
Number of subjects: 0
Study 32989771 — intervention group
Group type: COMPARATOR
Intervention: Waitlist-control group
Number of subjects: 0
Study 34883313 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive biomarker test result
Number of subjects: 1817
Study 34883313 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild and moderate symptoms of dementia
Number of subjects: 1817
Study 34883313 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease-modifying treatment available
Number of subjects: 1817
Study 33646265 — intervention group
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2-specific T cells
Number of subjects: 85
Study 33127581 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous auricular vagus nerve stimulation (taVNS)
Number of subjects: 37
Study 33127581 — intervention group
Group type: COMPARATOR
Intervention: Control groups (computer control, device sham control, earlobe stimulation control)
Number of subjects: 37
Study 35191198 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouth rinse with hydrogen peroxide (H2 O2) and hyaluronic acid (HA)
Number of subjects: 50
Study 35191198 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouth rinse
Number of subjects: 50
Study 34155684 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization using 395 genetic variants for systolic blood pressure
Number of subjects: 786
Study 34155684 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization using 391 genetic variants for diastolic blood pressure
Number of subjects: 786
Study 36456480 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergometrine combined with oxytocin (intra-myometrial injection following oxytocin intravenously)
Number of subjects: 298
Study 36456480 — intervention group
Group type: COMPARATOR
Intervention: Oxytocin alone (intra-myometrial injection following oxytocin intravenously)
Number of subjects: 298
Study 33640941 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommended non‐supervised physical activity (30 min/day) before and 4 weeks after surgery
Number of subjects: 400
Study 33640941 — intervention group
Group type: COMPARATOR
Intervention: Control group (no advice regarding physical activity)
Number of subjects: 400
Study 36420866 — intervention group
Group type: EXPERIMENTAL
Intervention: Honey (1 g kg-1 day-1) and Nigella sativa seeds (80 mg kg-1 day-1)
Number of subjects: 313
Study 36420866 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 313
Study 33638129 — intervention group
Group type: EXPERIMENTAL
Intervention: Counterclockwise rotation of the occlusal plane (CCWROP)
Number of subjects: 38
Study 33638129 — intervention group
Group type: COMPARATOR
Intervention: Control group (without CCWROP)
Number of subjects: 38
Study 32481277 — intervention group
Group type: EXPERIMENTAL
Intervention: Shexiang Tongxin Dropping Pills (STDP) combined with routine medicine
Number of subjects: 72
Study 32481277 — intervention group
Group type: COMPARATOR
Intervention: Nicorandil combined with routine medicine
Number of subjects: 72
Study 32481277 — intervention group
Group type: EXPERIMENTAL
Intervention: STDP combined with routine medicine
Number of subjects: 72
Study 33830503 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep brain anterior thalamus stimulation
Number of subjects: 110
Study 32332827 — intervention group
Group type: EXPERIMENTAL
Intervention: 40-Hz binaural beats (BB)
Number of subjects: 0
Study 32332827 — intervention group
Group type: EXPERIMENTAL
Intervention: 16-Hz binaural beats (BB)
Number of subjects: 0
Study 32332827 — intervention group
Group type: COMPARATOR
Intervention: No sound (control condition)
Number of subjects: 0
Study 35045943 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor (Radial access)
Number of subjects: 3984
Study 35045943 — intervention group
Group type: COMPARATOR
Intervention: Prasugrel (Radial access)
Number of subjects: 3984
Study 35045943 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor (Femoral access)
Number of subjects: 3984
Study 35045943 — intervention group
Group type: COMPARATOR
Intervention: Prasugrel (Femoral access)
Number of subjects: 3984
Study 32049331 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron isomaltoside 1000/ferric derisomaltose (IIM) - single dose of 1000 mg IV
Number of subjects: 1538
Study 32049331 — intervention group
Group type: COMPARATOR
Intervention: Iron sucrose (IS) - administered as 200 mg IV injections up to five times within a 2-week period
Number of subjects: 1538
Study 32619561 — intervention group
Group type: EXPERIMENTAL
Intervention: Calorically restricted ketogenic diet and intermittent fasting (KD‐IF)
Number of subjects: 50
Study 32619561 — intervention group
Group type: COMPARATOR
Intervention: Calorically unrestricted diet
Number of subjects: 50
Study 33962354 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid cognitive remediation (CR) with half sessions conducted remotely as homework
Number of subjects: 0
Study 33962354 — intervention group
Group type: COMPARATOR
Intervention: All in-clinic cognitive remediation (CR)
Number of subjects: 0
Study 32853164 — intervention group
Group type: EXPERIMENTAL
Intervention: Males
Number of subjects: 453
Study 32853164 — intervention group
Group type: EXPERIMENTAL
Intervention: Older adolescents
Number of subjects: 453
Study 32853164 — intervention group
Group type: EXPERIMENTAL
Intervention: Females
Number of subjects: 453
Study 32853164 — intervention group
Group type: EXPERIMENTAL
Intervention: All domains of aggression
Number of subjects: 453
Study 35879217 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate-dose prophylactic anticoagulation
Number of subjects: 375
Study 35879217 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose prophylactic anticoagulation
Number of subjects: 375
Study 35879217 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 375
Study 33900253 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible Periodization (FP)
Number of subjects: 32
Study 33900253 — intervention group
Group type: COMPARATOR
Intervention: Nonflexible Periodization (NP)
Number of subjects: 32
Study 35527624 — intervention group
Group type: EXPERIMENTAL
Intervention: GSI scanning protocol 1 (GSI profile: head and neck CTA)
Number of subjects: 100
Study 35527624 — intervention group
Group type: COMPARATOR
Intervention: GSI scanning protocol 2 (GSI profile: chest 80 mm)
Number of subjects: 100
Study 34923901 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral fecal microbiota transplantation (FMT) capsules for 12 weeks (A3)
Number of subjects: 0
Study 34923901 — intervention group
Group type: COMPARATOR
Intervention: Oral empty capsules for 12 weeks (B3)
Number of subjects: 0
Study 35553901 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC membrane n‐3 polyunsaturated fatty acids (PUFAs)
Number of subjects: 192
Study 35553901 — intervention group
Group type: EXPERIMENTAL
Intervention: N‐6 polyunsaturated fatty acids (PUFAs)
Number of subjects: 192